文献速递呼吸道感染呼吸危重症与机械通气

COVID-19危重症患者肺部微生物群与非消退性ARDS相关

Lung Microbiota of Critically Ill Patients with COVID-19 Are Associated with Nonresolving Acute Respiratory Distress Syndrome.
PubMed 文献 · Am J Respir Crit Care Med · 2022-01-01

本研究纳入114例机械通气的COVID-19 ARDS患者,通过支气管肺泡灌洗液16S/18S rRNA基因测序和定量PCR分析肺部微生物群。发现细菌和真菌负荷增高与60天拔管成功率降低及死亡率升高相关,肺部微生物群组成也与拔管成功相关,提示肺部微生物群是COVID-19相关ARDS异质性的重要因素。

要点

  • 细菌负荷每增加1 log10,拔管成功率降低(SHR 0.64,95%CI 0.42-0.97,P=0.034)。
  • 真菌负荷每增加1 log10,拔管成功率降低(SHR 0.59,95%CI 0.42-0.83,P=0.0027)。
  • 细菌负荷与死亡率相关(P=0.012),真菌负荷与死亡率相关(P=0.0498)。

核心结论

  • 肺部细菌和真菌微生物群与COVID-19中非消退性ARDS相关,是COVID-19相关ARDS异质性的重要贡献因素。

研究设计与样本

  • 观察性队列研究,纳入114例机械通气的COVID-19 ARDS患者,均行支气管镜BAL,用16S rRNA基因测序和定量PCR(靶向16S和18S rRNA基因)分析肺部微生物群。

主要发现

  • 细菌负荷每增加1 log10,拔管成功率降低(SHR 0.64,95%CI 0.42-0.97,P=0.034)。
  • 真菌负荷每增加1 log10,拔管成功率降低(SHR 0.59,95%CI 0.42-0.83,P=0.0027)。
  • 细菌负荷与死亡率相关(P=0.012),真菌负荷与死亡率相关(P=0.0498)。
  • 肺部微生物群组成与成功拔管相关(P=0.0045)。
  • 促炎细胞因子(如TNF-α)与微生物负荷相关。

临床怎么用

  • 在COVID-19相关ARDS机械通气患者中,可通过BAL评估肺部细菌和真菌负荷,辅助识别非消退性ARDS高风险患者。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Rationale: Bacterial lung microbiota are correlated with lung inflammation and acute respiratory distress syndrome (ARDS) and altered in severe coronavirus disease (COVID-19). However, the association between lung microbiota (including fungi) and resolution of ARDS in COVID-19 remains unclear. We hypothesized that increased lung bacterial and fungal burdens are related to nonresolving ARDS and mortality in COVID-19. Objectives: To determine the relation between lung microbiota and clinical outcomes of COVID-19-related ARDS. Methods: This observational cohort study enrolled mechanically ventilated patients with COVID-19. All patients had ARDS and underwent bronchoscopy with BAL. Lung microbiota were profiled using 16S rRNA gene sequencing and quantitative PCR targeting the 16S and 18S rRNA genes. Key features of lung microbiota (bacterial and fungal burden, α-diversity, and community composition) served as predictors. Our primary outcome was successful extubation adjudicated 60 days after intubation, analyzed using a competing risk regression model with mortality as competing risk. Measurements and Main Results: BAL samples of 114 unique patients with COVID-19 were analyzed. Patients with increased lung bacterial and fungal burden were less likely to be extubated (subdistribution hazard ratio, 0.64 [95% confidence interval, 0.42-0.97]; P = 0.034 and 0.59 [95% confidence interval, 0.42-0.83]; P = 0.0027 per log10 increase in bacterial and fungal burden, respectively) and had higher mortality (bacterial burden, P = 0.012; fungal burden, P = 0.0498). Lung microbiota composition was associated with successful extubation (P = 0.0045). Proinflammatory cytokines (e.g., tumor necrosis factor-α) were associated with the microbial burdens. Conclusions: Bacterial and fungal lung microbiota are related to nonresolving ARDS in COVID-19 and represent an important contributor to heterogeneity in COVID-19-related ARDS.

来源:Am J Respir Crit Care Med,查看原文。版权归原作者所有。

引用

  1. Kullberg RFJ, de Brabander J, Boers LS, et al. Lung Microbiota of Critically Ill Patients with COVID-19 Are Associated with Nonresolving Acute Respiratory Distress Syndrome. Am J Respir Crit Care Med. 2022. PMID: 35616585. doi:10.1164/rccm.202202-0274OC

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。